1-3 of 3
Michael R. Jensen
Close
Sort by
Journal Articles

Synergistic Interaction of the Heat Shock Protein 90 Inhibitor NVP-AUY922 and the Histone Deacetylase Inhibitor NVP-LBH589 in Multiple Myeloma

Martin Kaiser, Britta Lamottke, Michael R. Jensen, Cornelia Quadt, Carlos Garcia-Echeverria, Maren Mieth, Ulrike Heider, Orhan Sezer
Journal: Blood
Blood (2008) 112 (11): 5164.
https://doi.org/10.1182/blood.V112.11.5164.5164
Published: 2008
Journal Articles

Activity of New Heat Shock Protein 90 (hsp90) Inhibitor NVP-AUY922 Against Myeloma Cells Sensitive and Resistant to Conventional Agents.

Douglas W. McMillin, Joseph Negri, Jake Delmore, Patrick Hayden, Melissa Ooi, Nicholas Mitsiades, Robert Schlossman, Paul G. Richardson, Nikhil C. Munshi, Michael R. Jensen, Cornelia Quadt, Patrick Chène, Joseph Schoepfer, Carlos García-Echeverría, Kenneth C. Anderson, Constantine S. Mitsiades
Journal: Blood
Blood (2007) 110 (11): 1587.
https://doi.org/10.1182/blood.V110.11.1587.1587
Published: 2007
Journal Articles

Signaling Profile and Anti-Tumor Activity of the Novel HSP90 Inhibitor NVP-AUY922 in Multiple Myeloma.

Thorsten Stühmer, Angela Zöllinger, Daniela Siegmund, Manik Chatterjee, Evelyn Grella, Stefan Knop, Martin Kortüm, Christian Unzicker, Michael R. Jensen, Cornelia Quadt, Patrick Chène, Joseph Schoepfer, Carlos Garcia-Echeverria, Herrmann Einsele, Harald Wajant, Ralf C. Bargou
Journal: Blood
Blood (2007) 110 (11): 4788.
https://doi.org/10.1182/blood.V110.11.4788.4788
Published: 2007